Protalex Inc (PRTX) financial statements (2021 and earlier)

Company profile

Business Address 131 COLUMBIA TURNPIKE
FLORHAM PARK, NJ 07932
State of Incorp. DE
Fiscal Year End May 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100122
Cash and cash equivalents100122
Prepaid expense000000
Total current assets:110122
Noncurrent Assets
Intangible assets, net (including goodwill)000000
Intangible assets, net (excluding goodwill)000000
Total noncurrent assets:000000
TOTAL ASSETS:111123
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111101
Accounts payable001001
Accrued liabilities000000
Debt     4
Total current liabilities:111105
Noncurrent Liabilities
Long-term debt and lease obligation0     
Long-term debt, excluding current maturities0     
Liabilities, other than long-term debt22016139 
Due to related parties22016139 
Other undisclosed noncurrent liabilities011006
Total noncurrent liabilities:222171396
Total liabilities:32218141011
Stockholders' equity
Stockholders' equity attributable to parent, including:(2)(22)(17)(13)(8)(8)
Common stock000000
Additional paid in capital1027777736553
Accumulated deficit(104)(99)(95)(85)(74) 
Other undisclosed stockholders' equity attributable to parent     (62)
Total stockholders' equity:(2)(22)(17)(13)(8)(8)
TOTAL LIABILITIES AND EQUITY:111123

Income statement (P&L) ($ in millions)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Operating expenses(4)(3)(8)(11)(11)(5)
Other undisclosed operating loss(1)(1)(1)(1)(1)(0)
Operating loss:(4)(4)(9)(11)(12)(6)
Nonoperating income
(Investment Income, Nonoperating)
000000
Interest and debt expense(1)(1)(0)(0)(0)(1)
Loss from continuing operations before income taxes:(5)(5)(9)(12)(12)(6)
Income tax expense   (5)(5) 
Net loss:(5)(5)(9)(16)(17)(6)
Other undisclosed net income attributable to parent   55 
Net loss available to common stockholders, diluted:(5)(5)(9)(12)(12)(6)

Comprehensive Income ($ in millions)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Net loss:(5)(5)(9)(16)(17)(6)
Comprehensive loss, net of tax, attributable to parent:(5)(5)(9)(16)(17)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: